Related Experiment Videos
[Osteoporosis and inflammatory bowel disease]
L Menchén1, C Ripoll, I Bretón
1Servicio de Aparato Digestivo, Hospital General Universitario Gregorio Marañón, Madrid.
Nutricion Hospitalaria
|March 15, 2005
Summary
Inflammatory bowel disease (IBD) can lead to osteoporosis and osteopenia in up to 42% of patients. This review covers the causes, diagnosis, and treatment of bone density loss in IBD patients.
Area of Science:
- Gastroenterology
- Endocrinology
- Rheumatology
Context:
- Inflammatory bowel disease (IBD) is a chronic multisystemic disorder.
- Extraintestinal manifestations are common in IBD.
- Osteoporosis and osteopenia are significant complications of IBD.
Purpose:
- To review the clinical and etiological aspects of IBD-associated osteoporosis.
- To provide a diagnostic and treatment strategy for IBD-associated bone loss.
Summary:
- IBD affects up to 42% of patients with osteoporosis or osteopenia.
- Factors contributing to bone loss include inactivity, corticosteroid use, nutritional deficiencies, and the disease itself.
- This article discusses the clinical presentation, causes, and management of osteoporosis in IBD.
Impact:
- Highlights the prevalence and impact of osteoporosis in IBD patients.
- Offers a framework for managing this common complication.
- Aims to improve patient outcomes by addressing bone health in IBD care.